Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Dermal sheath cells help heal wounds by showing both skin and connective tissue traits.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

γδ T cells are essential for wound healing after poxvirus infection.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

Cytotoxic T cells cause hair loss in chronic alopecia areata.